Modulation of transthyretin expression
US8101743B2 · kind B2 · utility
40Cited by
213References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2008 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Nov 19, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/143333
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods are provided for modulating the expression of transthyretin. The compositions comprise oligonucleotides, targeted to nucleic acid encoding transthyretin. Methods of using these compounds for modulation of transthyretin expression and for diagnosis and treatment of diseases and conditions associated with expression of transthyretin are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.